On Wednesday 1 October, ahead of the forthcoming negotiations with the European Parliament (trilogue) on the pharmaceutical package, on 7 October, EU Member States backed the European Commission’s ambition to close this file by December.
At the meeting of the Committee of Permanent Representatives of the Member States to the EU (Coreper), it was broadly emphasised that, in times of uncertainty, “it is essential to provide legal certainty and clarity for patients, industry and Member...